Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,986 | Dovepress* | 7,986+ | 1,997 | 9,983 | |
Totals | 7,986 | 1,997 | 9,983 | ||
*Since 7 March 2008 +Since July 2016 |
View citations on Google Scholar